This article is more than 5 years old. Information may no longer be current.

FDA: Gilead recalls one lot of Vistide

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Subscribe

Added to email alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

One lot of cidofovir injection is being recalled because of the presence of particulate matter found in some of the vials, according to an FDA MedWatch advisory.

Cidofovir (Vistide, Gilead Sciences) is used to treat cytomegalovirus retinitis in patients with AIDS. The lot being recalled is number B120217A. The number is located on the product label on the side of the vials.

Gilead has notified its distributors and customers regarding the recall and is arranging for the recalled products to be returned. Health care providers should inspect the vials before injection to be sure that the vial is not from B120217A.

Health care professionals and pharmacists can contact Gilead Medical Information for more information at 1-800-445-3235.